Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.
The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,407,409 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and Sept. 9, 2022, to the Vaccine Adverse Event Reporting System (VAERS).
VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 14,438 U.S. deaths reported as of Sept. 9, 7% occurred within 24 hours of vaccination, 15% occurred within 48 hours of vaccination and 54% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 600 million COVID-19 vaccine doses had been administered as of Sept. 7, including 361 million doses of Pfizer, 230 million doses of Moderna and 19 million doses of Johnson & Johnson (J&J).
Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
VAERS data from Dec. 14, 2020, to Sept. 9, 2022, for 6-month-olds to 5-year-olds show:
- 3,730 adverse events, including 166 cases rated as serious and 6 reported deaths.
- 5 reports of myocarditis and pericarditis (heart inflammation).
The CDC uses a narrowed case definition of “myocarditis,” which excludes cases of cardiac arrest, ischemic strokes and deaths due to heart problems that occur before one has the chance to go to the emergency department.
- 26 reports of blood clotting disorders.
- 43 reports of seizures.
VAERS data from Dec. 14, 2020, to Sept. 9, 2022, for 5- to 11-year-olds show:
- 13,985 adverse events, including 655 rated as serious and 28 reported deaths.
- 45 reports of myocarditis and pericarditis.
- 67 reports of blood clotting disorders.
- 177 reports of seizures.
VAERS data from Dec. 14, 2020, to Sept. 9, 2022, for 12- to 17-year-olds show:
- 39,364 adverse events, including 4,2601 rated as serious and 121 reported deaths.
According to the CDC, “VAERS data available to the public include only the initial report data to VAERS. Updated data which contains data from medical records and corrections reported during follow up are used by the government for analysis. However, for numerous reasons including data consistency, these amended data are not available to the public.”
- 269 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 94% of cases attributed to Pfizer’s vaccine.
- 1,306 reports of myocarditis and pericarditis with 646 cases attributed to Pfizer’s vaccine.
- 301 reports of blood clotting disorders with 275 cases attributed to Pfizer.
- 26 cases of postural orthostatic tachycardia syndrome (POTS) with all cases attributed to Pfizer’s vaccine.
VAERS data from Dec. 14, 2020, to Sept. 9, 2022, for all age groups combined, show:
- 16% of deaths were related to cardiac disorders.
- 53% of those who died were male, 42% were female and the remaining death reports did not include the gender of the deceased.
- The average age of death was 72.
- As of Sept. 9, 12,230 pregnant women reported adverse events related to COVID-19 vaccines, including 4,876 reports of miscarriage or premature birth.
- Of the 16,330 cases of Bell’s Palsy reported, 75% were attributed to Pfizer vaccinations, 23% to Moderna and 4% to J&J.
- 2,954 reports of Guillain-Barré syndrome, with 66% of cases attributed to Pfizer, 20% to Moderna and 17% to J&J.
- 10,003 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
- 4,743 reports of myocardial infarction.
- 42,916 reports of blood-clotting disorders in the U.S. Of those, 29,445 reports were attributed to Pfizer, 9,630 reports to Moderna and 3,782 reports to J&J.
- 23,872 cases of myocarditis and pericarditis with 18,143 cases attributed to Pfizer, 5,296 cases to Moderna and 407 cases to J&J.
- 65 cases of Creutzfeldt-Jakob disease with 52 cases attributed to Pfizer, 12 cases to Moderna and 1 case to J&J.
- 524 cases of POTS with 387 cases attributed to Pfizer, 117 cases to Moderna and 21 cases to J&J.
CDC reports 5,300 errors in vaccine dose delivery in kids prior to authorization of new boosters
Errors include administering the wrong dose or the wrong product for a recipient’s age, using an undiluted vaccine when dilution was needed or administering a vaccine past its expiration date.
According to STAT, a search in VAERS showed reports of toddlers being given 10 times the amount of vaccine they were meant to receive. In at least one report, a child under age 2 was given the full contents of a 10-dose vial in error.
According to the CDC, there is no evidence administration errors have triggered more severe adverse events than are typically reported in children who have been given the correct dose of a vaccine.
Yet, the CDC’s vaccine advisory panel on Sept. 1 “voiced serious concerns” about the difficulties of keeping as many as 11 different brands and formulations of COVID-19 vaccines straight — as doctors’ offices, clinics and pharmacies across the U.S. give a primary series to young children, regular booster shots to older children and new bivalent boosters for people over age 12.
The current COVID-19 vaccine schedule allows doses of multiple vaccines to be administered in different volumes, some after dilution and many not, with intervals between doses ranging from three weeks to several months.
Exclusive: Woman injured by J&J vaccine has ‘never seen such meanness’
Sheila Bath, a 60-something chef and life coach from Connecticut, first suspected she’d been injured by the single-dose Johnson & Johnson (J&J) COVID-19 vaccine on April 11, 2021 — exactly 14 days after she got the vaccine.
In an exclusive interview with The Defender, Bath said her initial symptoms included a burning sensation running from her legs to her spine and numbness in her feet. The symptoms lasted for two months.
“My legs were burning from my ankle all the way up to my lower spine on both sides. Burning, burning, burning,” Bath said. “My feet were numb. It was burning out the nerves in my legs and in my spine.”
She said she also sustained “terrible bruising” on her extremities, dry mouth, worsening vision, inability to walk, cysts on her kidneys, gallstones in her bladder, calf cramps, muscle spasms, depression, brain fog and 20 lbs. of water-weight gain.
These are “classical Guillain-Barré Syndrome symptoms,” Bath said.
Bath suspected the vaccine triggered the symptoms, but doctors were initially reluctant to draw the same conclusion. She told The Defender:
“I didn’t know what Guillain-Barré was, but it’s a very well-known thing that you have to go directly to the hospital. And [my neurologist] could have sent me directly to the hospital. The neurologist neglected to follow the protocol of getting me into hospital when they could have cured it.”
“Three times I went back to him and he sent me home,” she said, telling her, “There’s nothing wrong with you. You’ve got neuropathy because you’re older.”
England study confirms deaths from myocarditis after COVID-19 vaccines
As The Defender reported on Thursday, the largest study to date on myocarditis deaths related to COVID-19 vaccination found that 100 people in England died of myocarditis soon after receiving a COVID-19 vaccine.
The study, published Aug. 22 in the American Heart Association’s journal, Circulation, found more than half (51) of the deaths occurred within 1 to 28 days after receiving a dose of the AstraZeneca vaccine and just under half (49) of the deaths occurred within 1 to 28 days after a dose of the Pfizer-BioNTech vaccine.
A team of 14 researchers looked at deaths after a hospital stay for myocarditis or with myocarditis listed as a cause of death on a death certificate among 42.8 million vaccinated people in England aged 13 and older between Dec. 1, 2020, and Dec. 15, 2021.
The researchers evaluated the association between vaccination and myocarditis for different ages and sex groups by tracking hospital admissions and deaths from myocarditis by age and gender and in relation to how many doses of a vaccine the person received.
About 20 million people got the AstraZeneca vaccine, 20 million got the Pfizer vaccine, and more than 1 million got the Moderna vaccine. Men under age 40, as a group, showed a heightened increased risk of myocarditis following all three vaccine types.
Although the study concluded the risk of myocarditis from SARS-CoV2 was greater than the risk of myocarditis from COVID-19 vaccines, there was no control group of unvaccinated people, the study was limited to the 28 days following vaccination and the conclusion didn’t hold true for all ages or all vaccines.
CDC director admits agency gave false information on COVID vaccine safety monitoring
CDC director Dr. Rochelle Walensky acknowledged publicly for the first time that the agency gave false information about its COVID-19 vaccine safety monitoring.
In a letter made public Sept.12, Walensky said the CDC did not analyze certain types of adverse event reports at all in 2021, despite the agency previously saying it began analyzing such reports in February 2021.
“CDC performed PRR [Proportional Reporting Ratio] analysis between March 25, 2022, through July 31, 2022,” Walensky said.
“CDC also recently addressed a previous statement made to the Epoch Times to clarify PRR were not run between February 26, 2021, to September 30, 2021.”
But the agency said in June it did not perform PRRs, and performing them was “outside th[e] agency’s purview.”
But just weeks later, the CDC said Su was wrong.
“CDC performed PRRs from March 25, 2022, through July 31, 2022,” a spokeswoman told The Epoch Times in August.
Walensky’s recent letter, dated Sept. 2, shows Walensky is aware her agency gave false information.
Court orders Bill Gates, Indian government to respond to lawsuit involving woman who died after AstraZeneca vaccine
An Indian court ordered Bill Gates, the Indian government and the Serum Institute of India — the world’s largest vaccine manufacturer — to provide formal responses relating to a case filed by the father of a 33-year-old doctor who died after receiving AstraZeneca’s Covishield COVID-19 vaccine.
The High Court of Judicature at Bombay set a Nov. 17 deadline for the responses and scheduled a hearing for the same day.
In a lawsuit filed in February, Dilip Lunawat alleged his daughter, Snehal Lunawat, died on March 1, 2021, of complications arising from the Covishield vaccine. He is seeking compensation of about $126 million.
According to Lunawat, his daughter was compelled as a health worker to get the Covishield vaccine and received assurances the vaccine was entirely safe and posed no risk to her health.
But just days after receiving her first dose on Jan. 28, 2021, Snehal developed severe headaches and vomiting and had to be hospitalized.
Doctors said Snehal was suffering from bleeding in the brain, low platelet count and blood-clot formation. After 14 days elapsed without her condition improving, Snehal’s family transferred her to another hospital, where she died eight days later.
Defendants in the case include Adar Poonawalla, CEO of the Serum Institute; Bill Gates, in his role as a partner in the development of the Covishield vaccine; the Indian Ministry of Health and Family Welfare; the Indian State of Maharashtra; India’s drug controller general; the former director of the All India Institute of Medical Science and others.
Rockefeller Foundation, nonprofits spend millions on research to ‘nudge’ people to get COVID Vaccines
The Rockefeller Foundation, the National Science Foundation and other nonprofits are pouring millions of dollars into a research initiative “to increase uptake of COVID-19 vaccines and other recommended public health measures by countering mis- and disinformation.”
In conjunction with the Social Science Research Council (SSRC), the Rockefeller Foundation last month announced $7.2 million in funding for the Mercury Project, initially launched in November 2021, under the slogan, “Together, we can build a healthier information environment.”
The funds will support 12 teams of researchers in 17 countries who will conduct studies on “ambitious, applied social and behavioral science to combat the growing global threat posed by low COVID-19 vaccination rates and public health mis- and disinformation,” the Rockefeller Foundation said.
The research will include “interventions that target the producers or the consumers of mis- and disinformation, or that increase confidence in reliable information.”
Some of the “interventions” include “literacy training for secondary school students” to “help students identify COVID-19 vaccine misinformation,” “equipping trusted messengers with communication strategies to increase COVID-19 vaccination demand” and “using social networks to share tailored, community-developed messaging to increase COVID-19 vaccination demand.”
This information will, according to the Rockefeller Foundation, “provide evidence about what works — and doesn’t — in specific places and for specific groups to increase COVID-19 vaccination take-up.”
Some critics described the project as one based on “propaganda” aimed at “nudging” the unvaccinated to get vaccinated.
Senate bill aims to end DC schools COVID vaccine mandate
Two Republican senators on Monday introduced a bill they said is designed to protect 12- to 15-year-old students in Washington, D.C., public schools from mandatory COVID-19 vaccinations.
U.S. Sens. Ted Cruz (R-Texas) and Marsha Blackburn (R-Tenn.) said their legislation, if enacted, would block a 2021 bill by the D.C. Council that amended a 1979 immunization law to add COVID-19 vaccines to the required list of childhood shots.
The senators said enforcement of the 2021 law would be “particularly harmful” to black students, who are at a lower vaccination rate than other students. Cruz said, in a statement, said the policy blatantly discriminates against black students in the nation’s capital as the vaccination rate for black students between the ages of 12 and 15 in Washington, D.C., is 60% — far lower than the city average.
Under the 2021 law, families are given 20 days from when they’re notified about non-compliance with the mandate to get their child vaccinated, or that student will not be allowed to attend class. Enforcement of the law was slated to begin for the 2022–2023 school year.